gucagon receptor antagonists (Janssen Pharmaceutical R & D)

N/A

Report date: 2025/01/26 18:49:12
NME

Base Information

Drug Namegucagon receptor antagonists (Janssen Pharmaceutical R & D)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon receptor antagonists
TargetsGlucagon receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A